These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety. Vorchheimer DA; Fuster V Circulation; 1998 Feb; 97(4):312-4. PubMed ID: 9468202 [No Abstract] [Full Text] [Related]
11. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena? Jackson G Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219 [No Abstract] [Full Text] [Related]
12. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology]. Abramovitch N; Halon DA; Flugelman Y; Lewis BS Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532 [No Abstract] [Full Text] [Related]
13. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients. Tricoci P; Peterson ED J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of platelet receptors GP IIB/IIIA: a new therapeutic class and its promise in the treatment of acute coronary syndromes]. Yerna M; Legrand V; Kulbertus H Rev Med Liege; 1997 May; 52(5):329-35. PubMed ID: 9273634 [No Abstract] [Full Text] [Related]
15. [Abciximab (ReoPro) in the treatment of acute coronary syndromes]. Rasmussen LH; Husted SE; Kassis E; Kastrup J; Kristensen SD; Pedersen KE; Grande P Ugeskr Laeger; 2001 Jan; 163(4):472-7. PubMed ID: 11218792 [TBL] [Abstract][Full Text] [Related]
16. Safety of the use of IIb/IIIa receptor blockers with or without the use of other anticoagulants. Ferguson JJ; Lau TK Semin Interv Cardiol; 1999 Jun; 4(2):97-102. PubMed ID: 10473879 [No Abstract] [Full Text] [Related]